Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers

Bavarian Gets Rights to New Cancer Vaccine Product Candidates

Bavarian Nordic A/S said its BN ImmunoTherapeutics subsidiary has agreed with the National Cancer Institute to jointly develop new off-the-shelf product candidates for the treatment of multiple cancers and a new technology platform based on NCI’s cancer vaccine technology.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.